You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 3, 2026

Claims for Patent: 11,040,113

✉ Email this page to a colleague

Summary for Patent: 11,040,113

Title:	Methods and pharmaceutical composition for the treatment and the prevention of neurological phenotype associated with Friedreich ataxia
Abstract:	The present invention relates to a vector which comprises a nucleic acid sequence encoding for the frataxin (FXN) gene for use in the prevention and treatment of neurological phenotype associated with Friedreich ataxia in a subject in need thereof.
Inventor(s):	Hélène PUCCIO, Françoise PIGUET
Assignee:	Centre National de la Recherche Scientifique CNRS , Institut National de la Sante et de la Recherche Medicale INSERM , Universite de Strasbourg
Application Number:	US15/560,620

Details for Patent 11,040,113

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Alexion Pharmaceuticals, Inc.	STRENSIQ	asfotase alfa	Injection	125513	October 23, 2015	⤷ Start Trial	2036-03-22
Pfizer Inc.	ABRYSVO	respiratory syncytial virus vaccine	Injection	125769	May 31, 2023	⤷ Start Trial	2036-03-22
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 11,040,113

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
European Patent Office	3273999	⤷ Start Trial
United States of America	2018050117	⤷ Start Trial
World Intellectual Property Organization (WIPO)	2016150964	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.